Systemic therapies post progression on CDK4/6 inhibitors in patients with oestrogen receptor positive metastatic breast cancer: Real world data from Guy's Cancer Centre. (November 2022) - Gousis, C.; Michoglou, K.; Lowe, H.; Akay, M.; Kapiris, M.; Angelis, V.